On Oct. 15, a jury determined that Johnson & Johnson must pay $15 million to local real-estate developer Evan Plotkin, who claims to have developed mesothelioma as […] ...
Researchers from Nanjing First Hospital reported that glutamine-fructose-6-phosphate transaminase 2 (GFPT2) may be considered a diagnostic and prognostic marker of mesothelioma.
Despite being banned in Singapore for 35 years, asbestos continues to claim lives through malignant mesothelioma, a cancer it causes. The nation's cases rose from five in the 1980s to 110 in 2019.
Some results have been hidden because they may be inaccessible to you